MyAverix Finance
NS · Healthcare
Goldline Pharmaceutical Ltd (544759)
Pharmaceuticals & Biotechnology
Goldline Pharmaceutical Ltd (544759) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $424.80M, P/E ratio is 10.31. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 544759
Goldline Pharmaceutical Ltd (544759) — FAQ
What is Goldline Pharmaceutical Ltd's market cap?
Goldline Pharmaceutical Ltd (544759) has a reported market cap of $424.80M (data as of 2026-07-10).
What is 544759's P/E ratio?
The price-to-earnings (P/E) ratio for Goldline Pharmaceutical Ltd (544759) is 10.31 (data as of 2026-07-10).
Does Goldline Pharmaceutical Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Goldline Pharmaceutical Ltd (544759). Check the MyAverix Finance app for the latest dividend data.
What sector is Goldline Pharmaceutical Ltd in?
Goldline Pharmaceutical Ltd (544759) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 544759 listed on?
544759 is listed on NS.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.